Emerald Bioscience, Inc.·4

Aug 12, 10:29 AM ET

DALESANDRO MARGARET 4

4 · Emerald Bioscience, Inc. · Filed Aug 12, 2020

Insider Transaction Report

Form 4
Period: 2020-08-07
Transactions
  • Award

    Director Option Grant (Right to Buy)

    2020-08-07+250,000250,000 total
    Exercise: $0.04Exp: 2030-08-07Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]Each of the Options shall be exercisable for a price of $0.045 per Option Share for ten years from August 7, 2020 (the "Grant Date") and all Options will vest 10% on the Grant Date and 90% in equal semiannual installments over two years.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT